Paper29326296
Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).
Creamer M and 12 others. J Neurol Neurosurg Psychiatry, 2018. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). Papers, record 29326296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29326296
- Disease
- Spasticity27 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).
- PubMed
- Publication types
- Clinical Trial, Phase IV, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Baclofen | Major topic |
| Muscle Relaxants, Central | Major topic |
| Muscle Spasticity | Major topic |
| Stroke | Major topic |
| Adult | |
| Aged | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Injections, Spinal | |
| Male | |
| Middle Aged | |
| Recovery of Function | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01032239 | SISTERS: Spasticity In Stroke Study - Randomized Study | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT07744659 | Spinal Cord Stimulation for Poststroke Spasticity | Background | ClinicalTrials.gov |
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11327562 | Intrathecal baclofen for spasticity caused by thrombotic stroke. | Am J Phys Med Rehabil | 2001 | https://conductscience.org/library/papers/11327562 | PubMed |
| 2 | 17084128 | Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. | Arch Phys Med Rehabil | 2006 | https://conductscience.org/library/papers/17084128 | PubMed |
| 3 | 8431095 | Functional assessment scales: a study of persons after stroke. | Arch Phys Med Rehabil | 1993 | https://conductscience.org/library/papers/8431095 | PubMed |
| 4 | 17145092 | [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke]. | Ann Readapt Med Phys | 2007 | https://conductscience.org/library/papers/17145092 | PubMed |
| 5 | 23885710 | Spasticity after stroke: physiology, assessment and treatment. | Brain Inj | 2013 | https://conductscience.org/library/papers/23885710 | PubMed |
| 6 | 23220492 | Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. | Toxicon | 2013 | https://conductscience.org/library/papers/23220492 | PubMed |
| 7 | 20515600 | BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. | Health Technol Assess | 2010 | https://conductscience.org/library/papers/20515600 | PubMed |
| 8 | 21992161 | Prospective 12-month study of intrathecal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement. | Neuromodulation | 2011 | https://conductscience.org/library/papers/21992161 | PubMed |
| 9 | 27711973 | Pharmacological interventions other than botulinum toxin for spasticity after stroke. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27711973 | PubMed |
| 10 | 12736875 | Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. | Arch Phys Med Rehabil | 2003 | https://conductscience.org/library/papers/12736875 | PubMed |
| 11 | 14143329 | PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. | Practitioner | 1964 | https://conductscience.org/library/papers/14143329 | PubMed |
| 12 | 23138834 | The pharmacological management of post-stroke muscle spasticity. | Drugs Aging | 2012 | https://conductscience.org/library/papers/23138834 | PubMed |
| 13 | 18458229 | Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. | Neurology | 2008 | https://conductscience.org/library/papers/18458229 | PubMed |
| 14 | 11546903 | Intrathecal baclofen for spastic hypertonia from stroke. | Stroke | 2001 | https://conductscience.org/library/papers/11546903 | PubMed |
| 15 | 21642057 | The underutilization of intrathecal baclofen in poststroke spasticity. | Top Stroke Rehabil | 2011 | https://conductscience.org/library/papers/21642057 | PubMed |
| 16 | 28233010 | Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen. | J Rehabil Med | 2017 | https://conductscience.org/library/papers/28233010 | PubMed |
| 17 | 18796543 | Limitations of intrathecal baclofen for spastic hemiparesis following stroke. | Neurorehabil Neural Repair | 2009 | https://conductscience.org/library/papers/18796543 | PubMed |
| 18 | 12917859 | Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. | Arch Phys Med Rehabil | 2003 | https://conductscience.org/library/papers/12917859 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42707787 | Comparative pharmacotherapeutic efficacy and dose-related safety profiles of intrathecal baclofen: a systematic review and meta-analysis in neurological spasticity. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42707787 | PubMed |
| 42243548 | Spinal cord stimulation for upper limb motor function in people with chronic post-stroke hemiparesis: a feasibility trial. | Nat Med | 2026 | https://conductscience.org/library/papers/42243548 | PubMed |
| 41882905 | 2024 Japan Society for Stereotactic and Functional Neurosurgery Guidelines for Stereotactic and Functional Neurosurgery. | Neurol Med Chir (Tokyo) | 2026 | https://conductscience.org/library/papers/41882905 | PubMed |
| 41626083 | Radial Extracorporeal Shock Wave Therapy for Lower-Limb Spasticity in an Individual With Subacute Stroke: A Case Report. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/41626083 | PubMed |
| 40438599 | Neurological adverse events associated with baclofen: a pharmacovigilance study based on FDA adverse event reporting system. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40438599 | PubMed |
| 40326554 | Current techniques for the treatment of spasticity and their effectiveness. | EFORT Open Rev | 2025 | https://conductscience.org/library/papers/40326554 | PubMed |
| 39754631 | Efficacy, Indications, and Safety of Intrathecal Baclofen Pump: A Narrative Review. | Curr Pain Headache Rep | 2025 | https://conductscience.org/library/papers/39754631 | PubMed |
| 39552923 | Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice. | Br J Pain | 2024 | https://conductscience.org/library/papers/39552923 | PubMed |
| 38678195 | Intrathecal baclofen efficacy for managing motor function and spasticity severity in patients with cerebral palsy: a systematic review and meta-analysis. | BMC Neurol | 2024 | https://conductscience.org/library/papers/38678195 | PubMed |
| 38610605 | Evaluating Community-Based Intrathecal Baclofen Therapy: Effectiveness, Safety, and Feasibility. | J Clin Med | 2024 | https://conductscience.org/library/papers/38610605 | PubMed |
| 38585026 | Intrathecal Baclofen Injection Efficacy for Spasticity Management in Patients With Stroke: A Meta-Analysis. | Brain Neurorehabil | 2024 | https://conductscience.org/library/papers/38585026 | PubMed |
| 38393176 | Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38393176 | PubMed |
| 37907224 | Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection. | Ann Rehabil Med | 2023 | https://conductscience.org/library/papers/37907224 | PubMed |
| 37743509 | Characteristics of Changes in Intrathecal Baclofen Dosage over Time due to Causative Disease. | Neurol Med Chir (Tokyo) | 2023 | https://conductscience.org/library/papers/37743509 | PubMed |
| 36287945 | Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36287945 | PubMed |
| 35836037 | The Options for Neuraxial Drug Administration. | CNS Drugs | 2022 | https://conductscience.org/library/papers/35836037 | PubMed |
| 34608495 | European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. | J Rehabil Med | 2022 | https://conductscience.org/library/papers/34608495 | PubMed |
| 34539344 | Sustained Baclofen-Induced Activation of GABA B Receptors After Cerebral Ischemia Restores Receptor Expression and Function and Limits Progressing Loss of Neurons. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/34539344 | PubMed |
| 34513041 | Intrathecal Baclofen Therapy in Russia: National Register, the Effect of One-Year Usage. | Sovrem Tekhnologii Med | 2020 | https://conductscience.org/library/papers/34513041 | PubMed |
| 32076591 | Spatiotemporal Distribution of Agrin after Intrathecal Injection and Its Protective Role in Cerebral Ischemia/Reperfusion Injury. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32076591 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ARHGEF2 | 9181 | PubTator's text mining | https://conductscience.org/library/genes/9181 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| BACLOFEN | CHEMBL701 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL701 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29326296
GET https://conductscience.org/api/papers/v1/29326296/cited_by?page=2